Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor
- PMID: 15210579
- PMCID: PMC1575114
- DOI: 10.1038/sj.bjp.0705868
Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor
Abstract
1 Extracellular ATP can activate a cation-selective channel/pore on human B-lymphocytes, known as the P2X7 receptor. Activation of this receptor is linked to PLD stimulation. We have used ATP-induced 86Rb+ (K+) efflux to examine the effect of benzophenanthridine alkaloids on P2X7 channel/pore function in human B-lymphocytes. 2 Both ATP and the nucleotide analogue 2'-3'-O-(4-benzoylbenzoyl)-ATP (BzATP) induced an 86Rb+ efflux, which was completely inhibited by the isoquinoline derivative 1-(N,O-bis[5-isoquinolinesulphonyl]-N-methyl-l-tyrosyl)-4-phenylpiperazine (KN-62), a potent P2X7 receptor antagonist. 3 The benzophenanthridine alkaloid chelerythrine, a potent PKC inhibitor, inhibited the ATP-induced 86Rb+ efflux by 73.4+/-3.5% and with an IC50 of 5.6+/-2.3 microm. Similarly, other members of this family of compounds, sanguinarine and berberine, blocked the ATP-induced 86Rb+ efflux by 58.8+/-4.8 and 61.1+/-8.0%, respectively. 4 Concentration-effect curves to ATP estimated an EC50 value of 78 microm and in the presence of 5 and 10 microm chelerythrine this increased slightly to 110 and 150 microm, respectively, which fits a noncompetitive inhibitor profile for chelerythrine. 5 Chelerythrine at 10 microm was effective at inhibiting the ATP-induced PLD stimulation in B-lymphocytes by 94.2+/-21.9% and the phorbol 12-myristate 13-acetate-induced PLD stimulation by 68.2+/-7.4%. 6 This study demonstrates that chelerythrine in addition to PKC inhibition has a noncompetitive inhibitory action on the P2X7 receptor itself.
Figures




References
-
- BOUE-GRABOT E., ARCHAMBAULT V., SEGUELA P. A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X2 ATP-gated channels. J. Biol. Chem. 2000;275:10190–10195. - PubMed
-
- CHO H., YOUM J.B., EARM Y.E., HO W.K. Inhibition of acetylcholine-activated K+ current by chelerythrine and bisindoylmaleimide I in atrial myocytes from mice. Eur. J. Pharmacol. 2001;424:73–178. - PubMed
-
- COHEN H.G., SEIFEN E.E., STRAUB K.D., TIEFENBACK C., STERMITZ F.R. Structural specificity of NaK-ATPase inhibition by sanguinarine, an isoquinoline benzophenanthridine alkaloid. Biochem. Pharmacol. 1978;27:2555–2558. - PubMed
-
- DUBYAK G.R.Role of P2 receptors in the immune system Purinergic and Pyrimidinergic Signalling II 2001Berlin: Springer Verlag; 323–355.ed. Abbracchio, M.P. & Williams, M. pp
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous